Literature DB >> 19032223

Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria.

M Ravaioli1, G L Grazi, F Piscaglia, F Trevisani, M Cescon, G Ercolani, M Vivarelli, R Golfieri, A D'Errico Grigioni, I Panzini, C Morelli, M Bernardi, L Bolondi, A D Pinna.   

Abstract

Conventional criteria for liver transplantation for patients with hepatocellular carcinoma are single HCC <or= 5 cm or less than or equal to three HCCs <or= 3 cm. We prospectively evaluated the possibility of slightly extending these criteria in a down-staging protocol, which included patients initially outside conventional criteria: single HCC 5-6 cm or two HCCs <or= 5 cm or less than six HCCs <or= 4 cm and sum diameter <or= 12 cm, but within Milan criteria in the active tumors after the down-staging procedures. The outcome of patients down-staged was compared to that of Milan criteria after liver transplantation and since the first evaluation according to an intention-to-treat principle. From 2003 to 2006, 177 patients with HCC were considered for transplantation: the transplantation rate was comparable between the Milan and down-staging groups: 88/129 cases (68%) versus 32/48 cases (67%), respectively. At a median follow-up of 2.5 years after transplantation, the 1 and 3 years' disease-free survival rates were comparable: 80% and 71% in the Milan group versus 78% and 71% in the down-staging. The actuarial intention-to-treat survival was 27/48 patients (56.3%) in the down-staging and 81/129 cases (62.8%) in the Milan group, p = n.s. The proposed down-staging criteria provide a comparable outcome to the conventional criteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19032223     DOI: 10.1111/j.1600-6143.2008.02409.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  102 in total

1.  Liver transplantation for hepatocellular carcinoma on cirrhosis: strategies to avoid tumor recurrence.

Authors:  Marco Vivarelli; Andrea Risaliti
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Neoadjuvant Locoregional Therapy and Recurrent Hepatocellular Carcinoma after Liver Transplantation.

Authors:  Min Xu; Mb Majella Doyle; Babak Banan; Neeta Vachharajani; Xuanchuan Wang; Nael Saad; Kathryn Fowler; Elizabeth M Brunt; Yiing Lin; William C Chapman
Journal:  J Am Coll Surg       Date:  2017-04-09       Impact factor: 6.113

Review 3.  Hepatocellular carcinoma review: current treatment, and evidence-based medicine.

Authors:  Ali Raza; Gagan K Sood
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

4.  Significance of platelet count in the outcomes of hepatectomized patients with hepatocellular carcinoma exceeding the Milan criteria.

Authors:  Hironobu Amano; Hirotaka Tashiro; Akihiko Oshita; Tsuyoshi Kobayashi; Yoshisato Tanimoto; Shintaro Kuroda; Hirofumi Tazawa; Toshiyuki Itamoto; Toshimasa Asahara; Hideki Ohdan
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

Review 5.  Treatment of hepatocellular carcinoma: Steps forward but still a long way to go.

Authors:  Liat Mlynarsky; Yoram Menachem; Oren Shibolet
Journal:  World J Hepatol       Date:  2015-03-27

Review 6.  Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.

Authors:  Maurizio Pompili; Giampiero Francica; Francesca Romana Ponziani; Roberto Iezzi; Alfonso Wolfango Avolio
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

7.  Outcome comparisons among the Hangzhou, Chengdu, and UCSF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies.

Authors:  Jianyong Lei; Lunan Yan
Journal:  J Gastrointest Surg       Date:  2013-01-17       Impact factor: 3.452

Review 8.  Advances in managing hepatocellular carcinoma.

Authors:  Marielle Reataza; David K Imagawa
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

9.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

10.  Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma.

Authors:  Matteo Cescon; Matteo Ravaioli; Gian Luca Grazi; Giorgio Ercolani; Alessandro Cucchetti; Valentina Bertuzzo; Gaetano Vetrone; Massimo Del Gaudio; Marco Vivarelli; Antonietta D'Errico-Grigioni; Alessandro Dazzi; Paolo Di Gioia; Augusto Lauro; Antonio Daniele Pinna
Journal:  J Transplant       Date:  2010-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.